HIV/AIDS Drugs, Patents and the TRIPS Agreement : Issues and Options.
Examines current dispute between the research-based pharmaceutical industry and certain foreign governments, patient advocacy groups and generic manufacturers regarding patented HIV/AIDS drugs. Reviews fundamentals of patent protection for pharmaceuticals domestically and abroad, and discusses medic...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
2001.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines current dispute between the research-based pharmaceutical industry and certain foreign governments, patient advocacy groups and generic manufacturers regarding patented HIV/AIDS drugs. Reviews fundamentals of patent protection for pharmaceuticals domestically and abroad, and discusses medications used in treating HIV/AIDS. Describes international controversies regarding patents on HIV/AIDS drugs and the potential consequences of these disputes for entrepreneurial drug companies. Reviews legislative issues and options. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |